Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Gilead Sciences, Merck collaborate to evaluate Trodelvy in combo with Keytruda

Ruchika Sharma31 Oct 2021 9:30 AM IST

Foster City: Gilead Sciences, Inc. has recently announced the company has entered into a clinical trial collaboration and supply agreement with Merck...

GSK Pharma net profit jumps over two-folds to Rs 204 crore in Q3

Ruchika Sharma31 Oct 2021 9:15 AM IST

New Delhi: GlaxoSmithKline (GSK) Pharmaceuticals on friday posted an over two-fold increase in its consolidated net profit at Rs 204.24 crore for the...

Altogether six senior doctors of AIIMS Bhopal resigned last year due to lack of administrative improvements

Compliance officer of Dr Reddy's Labs resigns

Ruchika Sharma31 Oct 2021 9:00 AM IST

Hyderabad: Dr Reddy's Laboratories has recently announced that Mr. Sandeep Poddar, Company Secretary and Compliance Officer of the Company, has...

Dr Reddy's Labs gets 8 USFDA observations for Duwada facilities

Ruchika Sharma30 Oct 2021 2:36 PM IST

Hyderabad: Drugmaker, Dr. Reddy's Laboratories has recently announced that the U. S. Food and Drug Administration (USFDA) has concluded an audit...

Optimus Pharma seeks DCGI nod to produce generic version of Molnupiravir

Ruchika Sharma30 Oct 2021 2:21 PM IST

Optimus' price of 40 cents per capsule is in line with market competition, said Reddy.

Delhi doctor brutally murdered by male dietician over alleged sexual harassment

Indian-origin pharma CEO shot dead by gunman in US for robbery

Ruchika Sharma30 Oct 2021 2:00 PM IST

New York: An Indian-origin top executive of a pharmaceutical company in the US state of New Jersey was shot dead by a gunman who followed him home...

Dr Reddy's Labs launches Ephedrine Sulfate Injection in US

Ruchika Sharma30 Oct 2021 1:33 PM IST

Hyderabad: Dr. Reddy's Laboratories Ltd. has recently announced the launch of Ephedrine Sulfate Injection USP, 50 mg/mL in the U.S. Market.The...

FIRST: Pfizer-BioNTech gets USFDA emergency use nod for COVID vaccine in kids aged 5 through 11 years old

Ruchika Sharma30 Oct 2021 1:31 PM IST

New York: Pfizer Inc. and BioNTech SE have recently announced that the U.S. Food and Drug Administration (USFDA) has authorized for emergency use...

Russian COVID vaccine: Dr Reddys likely to submit Sputnik light trial data to DCGI in November

Ruchika Sharma30 Oct 2021 11:00 AM IST

New Delhi: Dr. Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian...

We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly: WHO official on Covaxin EUL

Ruchika Sharma29 Oct 2021 3:46 PM IST

United Nations/Geneva: India's Bharat Biotech has been submitting data on the EUL of Covaxin "regularly and very quickly" to a technical committee...

Bharat Biotech Covaxin finds place in Oman list of approved COVID vaccines

Ruchika Sharma29 Oct 2021 3:46 PM IST

New Delhi: Bharat Biotech's Covaxin has been included to the approved list of COVID-19 vaccines for travel to Oman without quarantine.In a tweet,...

Pfizer, BioNTech to provide additional 50 Million Pediatric doses of COVID-19 Vaccine to US

Ruchika Sharma29 Oct 2021 3:33 PM IST

New York: Pfizer Inc. and BioNTech SE have announced that the U.S. government has purchased 50 million more doses of the companies' COVID-19 vaccine....

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok